Cargando…

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

Low grade serous ovarian tumours are a rare and under-characterised histological subtype of epithelial ovarian tumours, with little known of the molecular drivers and facilitators of tumorigenesis beyond classic oncogenic RAS/RAF mutations. With a move towards targeted therapies due to the chemoresi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunter, Sally M., Anglesio, Michael S., Ryland, Georgina L., Sharma, Raghwa, Chiew, Yoke-Eng, Rowley, Simone M., Doyle, Maria A., Li, Jason, Gilks, C. Blake, Moss, Phillip, Allan, Prue E., Stephens, Andrew N., Huntsman, David G., deFazio, Anna, Bowtell, David D., Gorringe, Kylie L., Campbell, Ian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741956/ https://www.ncbi.nlm.nih.gov/pubmed/26506417

Ejemplares similares

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2010)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015)

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
por: Helland, Åslaug, et al.
Publicado: (2011)

Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)

MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers
por: Ryland, Georgina L., et al.
Publicado: (2012)

Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
por: Davis, Sally J, et al.
Publicado: (2011)

The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors()()
por: Wang, Yemin, et al.
Publicado: (2015)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
por: Gilks, C. Blake
Publicado: (2010)

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
por: Etemadmoghadam, Dariush, et al.
Publicado: (2010)

MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
por: Lee, Cheng-Han, et al.
Publicado: (2009)

The molecular origin and taxonomy of mucinous ovarian carcinoma
por: Cheasley, Dane, et al.
Publicado: (2019)

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
por: Bashashati, Ali, et al.
Publicado: (2013)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
por: Subramanian, Deepak N., et al.
Publicado: (2020)

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013)

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
por: Christie, Elizabeth L., et al.
Publicado: (2019)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

CONTRA: copy number analysis for targeted resequencing
por: Li, Jason, et al.
Publicado: (2012)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

A simple consensus approach improves somatic mutation prediction accuracy
por: Goode, David L, et al.
Publicado: (2013)

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery
por: Chay, Wen Yee, et al.
Publicado: (2015)

No evidence for PALB2 methylation in high-grade serous ovarian cancer
por: Mikeska, Thomas, et al.
Publicado: (2013)

Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis
por: Emmanuel, Catherine, et al.
Publicado: (2011)

Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation
por: Pradhan, Manohar, et al.
Publicado: (2010)

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
por: Wiegand, Kimberly C, et al.
Publicado: (2014)

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
por: Jung, MoonSun, et al.
Publicado: (2018)

Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma
por: Pitiyarachchi, Omali, et al.
Publicado: (2023)

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
por: Harrington, Brittney S, et al.
Publicado: (2016)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
por: Turashvili, Gulisa, et al.
Publicado: (2009)

Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
por: Anglesio, Michael S, et al.
Publicado: (2015)

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_v9jihdj9lnet862ks8an925rka